ClinConnect ClinConnect Logo
Search / Trial NCT05159856

Early Detection of Long-term Diabetic Complications in Children and Adolescents With Type 1 Diabetes

Launched by STENO DIABETES CENTER COPENHAGEN · Dec 2, 2021

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Pediatric Arteriel Stiffness Pulse Wave Velosity Neuropathy Type 1 Diabetes Early Diabetic Complications

ClinConnect Summary

This clinical trial is studying how to detect early signs of long-term complications in children and teenagers with type 1 diabetes (T1D). Researchers want to understand the relationship between factors like blood sugar control, nerve function, and arterial stiffness, which can indicate potential health issues later on. The goal is to improve the health and quality of life for kids with T1D by finding ways to better monitor and manage their condition early on.

To participate, children aged 6 to 18 who have had T1D for more than a year can join the study. They will be followed at the Pediatric Diabetes outpatient clinic in Copenhagen, and their guardians must give consent. Participants will undergo various tests, including blood tests and physical examinations, and they will be invited to return for check-ups every five years over the next two decades. This study aims to gather important information that may help identify those who need extra care to prevent serious complications from diabetes.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • T1D\>12 months
  • 6-18 years old prior to inclusion
  • Followed at the Pediatric Diabetes outpatient clinic at Steno Diabetes Center Copenhagen
  • Speaks and reads Danish well enough to understanding the given oral and written information.
  • There is a written consent from the guardianship holder/holders for the child.
  • Exclusion Criteria:
  • T1D \< 12 months
  • Known cardiovascular disease
  • Antihypertensive treatment

About Steno Diabetes Center Copenhagen

Steno Diabetes Center Copenhagen is a leading clinical research facility dedicated to advancing the understanding and treatment of diabetes and its complications. As a prominent sponsor of clinical trials, the center focuses on innovative research that bridges clinical practice and scientific inquiry, fostering collaborations with healthcare professionals, researchers, and patients. Committed to improving patient outcomes, Steno Diabetes Center Copenhagen emphasizes evidence-based approaches and cutting-edge methodologies to enhance diabetes management and care, ultimately contributing to the global fight against this chronic disease.

Locations

Herlev, , Denmark

Patients applied

0 patients applied

Trial Officials

jesper johannesen

Principal Investigator

Steno Diabetes Center Copenhagen

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials